A PHASE III STUDY OF ENOXAPARIN VS ASPIRIN AS THROMBOPROPHYLAXIS FOR PATIENTS WITH NEWLY DIAGNOSED OF MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE-BASED REGIMENS.
Federica Cavallo, Antonio Palumbo(University Hospital Brno), Roberto Ria(University of Bari Aldo Moro), Tommasina Guglielmelli(Azienda Ospedaliero Universitaria San Giovanni Battista), Mario Boccadoro(University of Turin), Alessandra Larocca(Cornell University), Giulia Benevolo(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Norbert Pescosta(Fondazione Gimema Onlus), Francesco Di Raimondo(University of Catania), Tommaso Caravita(Azienda Ospedaliero Universitaria San Giovanni Battista), Clotilde Cangialosi(Azienda Ospedaliero Universitaria San Giovanni Battista), Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Giovannino Ciccone(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Lucio Catalano(University of Naples Federico II), Luca Baldini(University of Milan), Magda Marcatti(Vita-Salute San Raffaele University), Barbara Lupo(University of Turin), Annastella Falcone, Anna Baraldi(Fondazione Gimema Onlus), Luciano Masini(Casa di Cura Villa Garda), A Nagler, Massimo Galli(Luigi Sacco Hospital)
Unknown
January 1, 2011
Cited by 3
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k